← 返回

回复 Fukui 等人关于“治疗后 TIL(肿瘤浸润淋巴细胞)增加与雌激素受体阳性/HER2 阴性乳腺癌新辅助内分泌治疗反应不佳显著相关”的评论

英文原题:Reply to comment on 'An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers' by Fukui et al.

查看英文原题

Reply to comment on 'An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers' by Fukui et al.

PubMed 2024/03/04(内容时间) Breast Cancer Q1 · IF 3.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

摘要

这条来源本身就没有摘要(PubMed 未提供),不是「还没翻译」。可以点最下面的「在 PubMed 查看」打开原文献页面。

论文信息

作者
Fukui R、Watanabe T、Morimoto K、Fujimoto Y、Nagahashi M、Ishikawa E、Hirota S、Miyoshi Y
第一作者单位
Department of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Mukogawa-cho 1-1, Nishinomiya City, Hyogo, 663-8501, Japan.Japan
通讯作者单位
Department of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Mukogawa-cho 1-1, Nishinomiya City, Hyogo, 663-8501, Japan. ymiyoshi@hyo-med.ac.jp.Japan
文献类型
读者来信
期刊
Breast cancer (Tokyo, Japan)2024 May
原文标识
PubMed 38433180 · DOI 10.1007/s12282-024-01552-y